Headline
The latest stories from AHA Today.
The Department of Health and Human Services Aug. 7 announced it will no longer fund mRNA vaccine development under the Biomedical Advanced Research and Development Authority.
A new analysis published Aug. 6 by the Peterson Center on Healthcare and KFF found that Health Insurance Marketplace insurers will propose a median premium increase of 18% for 2026.
The Centers for Disease Control and Prevention Aug. 5 announced a new campaign educating youth ages 12-17 on substance use, mental health and how they are connected.
The AHA will host its inaugural Healthier Together Conference May 12-14, 2026, in Dallas.
Nell Buhlman, chief administrative officer and head of strategy at Press Ganey, and Chris DeRienzo, M.D., AHA chief physician executive, explore the data-backed connection between employee engagement and patient outcomes.
Patients in the hospital for surgeries had better outcomes in 2024 than they did in 2019, according to a new report released today by the AHA and Vizient.
A JAMA study published yesterday found that more adults age 45-49 have been diagnosed with colorectal cancer, a finding that coincides with recommendations by the American Cancer Society in 2018 and the United States Preventive Services Task Force in 2021 to lower the screening age from 50 to 45.
The AHA today filed an amicus brief in the U.S. Court of Appeals for the D.C. Circuit, defending the Department of Health and Human Services’ decision to prevent drug companies from implementing a 340B rebate model. The brief was filed in a consolidated appeal involving five drug companies. The AHA…
The Food and Drug Administration has identified a Class I recall of Philips Respironics V30, A30 and A40 ventilators due to the potential for serious injury or death.
Nearly 57% of mothers did not attend a postpartum follow-up visit three to eight weeks after giving birth, according to a report published July 29 by Cedar Gate Technologies.